NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 216 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $8 | -78.4% | 13,675 | -16.6% | 0.00% | -80.0% |
Q4 2022 | $37 | -100.0% | 16,394 | -29.5% | 0.01% | -89.8% |
Q4 2019 | $502,000 | +19.8% | 23,260 | +97.5% | 0.05% | +96.0% |
Q2 2019 | $419,000 | +46.0% | 11,780 | -48.6% | 0.02% | -3.8% |
Q2 2015 | $287,000 | +50.3% | 22,907 | +44.6% | 0.03% | +30.0% |
Q3 2014 | $191,000 | – | 15,840 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |